Jim Simons Anixa Biosciences Inc Call Options Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANIX
# of Institutions
59Shares Held
5.16MCall Options Held
14.5KPut Options Held
24.3K-
Vanguard Group Inc Valley Forge, PA1.39MShares$3.08 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC604KShares$1.34 Million0.26% of portfolio
-
Ubs Group Ag536KShares$1.19 Million0.0% of portfolio
-
Mission Wealth Management, LP502KShares$1.11 Million0.04% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA341KShares$753,5010.0% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $67.8M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...